- Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
-
Shorts
-
CORRESP Filing
Zymeworks CORRESPCorrespondence with SEC
Filed: 30 Aug 22, 12:00am
August 30, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Technology
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: | Conlon Danberg | |
Suzanne Hayes |
Re: | Zymeworks Delaware Inc. | |||
Registration Statement on Form S-4 | ||||
(File No. 333-266160) | ||||
Acceleration Request | ||||
Requested Date: | Friday, September 2, 2022 | |||
Requested Time: | 4:00 P.M. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Zymeworks Delaware Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-4 (File No. 333-266160) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Bryan D. King at (206) 883-2535 or Laura Duncan at (206) 883-2578.
[Signature page follows]
Securities and Exchange Commission
August 30, 2022
Page 2
Sincerely, |
ZYMEWORKS DELAWARE INC. |
/s/ Kenneth Galbraith |
Kenneth Galbraith |
Chair, President and Chief Executive Officer |
Enclosures
cc: | Daniel Dex, Zymeworks Inc. |
Tony Jeffries, Wilson Sonsini Goodrich & Rosati P.C.
Bryan D. King, Wilson Sonsini Goodrich & Rosati P.C.
Joseph Garcia, Blake, Cassels & Graydon LLP
Jamie Kariya, Blake, Cassels & Graydon LLP